“The FDA GRAS certification demonstrates our commitment to a higher level of safety and quality for this ingredient,” said Mike Kolifrath, vice president, sales and marketing of the Probiotics Division at Kaneka. “Brands can be assured to have best in class ingredient when selecting to use the Cardio Probiotic raw material blend in their products for lipid metabolism and cardiovascular benefits.”
Cardio Probiotic is a clinically tested formulation of three strains that specifically supports healthy total cholesterol, LDL and HDL levels already in normal range. The three Lactobacillus plantarum strains used in the Cardio Probiotic formula were initially isolated via a screening process specifically designed to identify strains that have a beneficial effect on lipid metabolism.
Cardio Probiotic is part of the Kaneka Probiotics Portfolio of products based on a mechanistic approach to identify optimal strains for specific health applications. The company said its strain library collection has over 1,000+ strains strategically sourced from populations around the world with conserved microbiomes.
The Kaneka Probiotics portfolio includes formulations for Immune, Upper Respiratory Tract Infection, Digestion, GI Challenges, Oral-Gum Health, Colic, Women's, Gut-Brain Axis, Cardiovascular, and Stress/Mood/Anxiety.